Novel peptide binds EWS-FLI1 and reduces the oncogenic potential in Ewing tumors.
about
Potential approaches to the treatment of Ewing's sarcomaManagement of Ewing sarcoma family of tumors: Current scenario and unmet needVorinostat Enhances Cytotoxicity of SN-38 and Temozolomide in Ewing Sarcoma Cells and Activates STAT3/AKT/MAPK PathwaysTargeting the DNA-binding activity of the human ERG transcription factor using new heterocyclic dithiophene diamidinesEpidemiology and therapies for metastatic sarcomaPolycation-π interactions are a driving force for molecular recognition by an intrinsically disordered oncoprotein family.The first European interdisciplinary ewing sarcoma research summitEWS-FLI-1-targeted cytotoxic T-cell killing of multiple tumor types belonging to the Ewing sarcoma family of tumorsMolecular detection and targeting of EWSR1 fusion transcripts in soft tissue tumorsStructures of mithramycin analogues bound to DNA and implications for targeting transcription factor FLI1.Biomarkers of Osteosarcoma, Chondrosarcoma, and Ewing Sarcoma.Optimal management of Ewing sarcoma family of tumors: recent developments in systemic therapy.Blocking the road, stopping the engine or killing the driver? Advances in targeting EWS/FLI-1 fusion in Ewing sarcoma as novel therapy.Structure-function based molecular relationships in Ewing's sarcoma.A polypeptide from the junction region sequence of EWS-FLI1 inhibits Ewing's sarcoma cells, interacts with the EWS-FLI1 and partner proteins.Microsatellites with macro-influence in ewing sarcoma
P2860
Q28072744-2E4C6191-EBB3-4275-8406-1FEA68F70233Q28073218-361BFE44-F692-4706-A540-3BB41A6B527AQ28550980-E2A330DD-3574-4938-BB64-3D5FEE3267AEQ28771722-09F1F109-B39E-4F0F-9354-6532B72DB3F8Q34652142-4E75CB74-A162-4719-8F2B-FB2A0570F230Q35004442-98A95495-D8FD-4178-B2B1-B6BDD40B8CEEQ35993560-D7EFB68B-C974-4E5E-9AFD-86074439423FQ36295912-8125CD45-813B-4885-81EB-D134F2D3B95FQ36651015-0A302845-6342-4E57-B851-0D594DC438F9Q37336991-7D7009D5-9158-4023-8AD0-2145DBA9B1B6Q37740672-8108ABF7-791F-4E91-B09C-19462B5F8636Q38113988-3B88220B-1073-47E4-A1AC-96EFEF41EF0CQ38243878-554F7E09-E146-44BD-AEBC-A0F5FCB3CA7BQ38358141-3BCEE2A1-6717-4A69-86C8-E4E50C628346Q41243739-94DC5809-9BF5-4621-8F81-BFA9EDD49BAEQ41887497-5404DFF5-AB6C-4876-8136-D5F36B93E7D9
P2860
Novel peptide binds EWS-FLI1 and reduces the oncogenic potential in Ewing tumors.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Novel peptide binds EWS-FLI1 and reduces the oncogenic potential in Ewing tumors.
@ast
Novel peptide binds EWS-FLI1 and reduces the oncogenic potential in Ewing tumors.
@en
Novel peptide binds EWS-FLI1 and reduces the oncogenic potential in Ewing tumors.
@nl
type
label
Novel peptide binds EWS-FLI1 and reduces the oncogenic potential in Ewing tumors.
@ast
Novel peptide binds EWS-FLI1 and reduces the oncogenic potential in Ewing tumors.
@en
Novel peptide binds EWS-FLI1 and reduces the oncogenic potential in Ewing tumors.
@nl
prefLabel
Novel peptide binds EWS-FLI1 and reduces the oncogenic potential in Ewing tumors.
@ast
Novel peptide binds EWS-FLI1 and reduces the oncogenic potential in Ewing tumors.
@en
Novel peptide binds EWS-FLI1 and reduces the oncogenic potential in Ewing tumors.
@nl
P2093
P2860
P356
P1433
P1476
Novel peptide binds EWS-FLI1 and reduces the oncogenic potential in Ewing tumors.
@en
P2093
Aykut Üren
Hayriye V Erkizan
Jeffrey A Toretsky
Julie S Barber-Rotenberg
Kamal P Sajwan
Lauren J Scher
S Ellen Gamble
P2860
P304
P356
10.4161/CC.10.19.17734
P577
2011-10-01T00:00:00Z